We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$93.4B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$104B
AUM Growth
+$12.8B
(+14%)
Cap. Flow
+$10.7B
Cap. Flow
% of AUM
10.27%
Top 10 Holdings %
Top 10 Hldgs %
37.32%
Holding
3,165
New
694
Increased
888
Reduced
890
Closed
626
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| 1 | Technology | 19.25% |
| 2 | Consumer Discretionary | 13.51% |
| 3 | Healthcare | 11.06% |
| 4 | Financials | 8.19% |
| 5 | Communication Services | 6.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SY
2476
So-Young International
SY
$172M
| $45.3K | ﹤0.01% |
+17,683
| New | +$57.4K |
|
2477
Eledon Pharmaceuticals
ELDN
$297M
| $44.6K | ﹤0.01% |
+29,547
| New | +$70.2K |
|
2478
Acumen Pharmaceuticals
ABOS
$190M
| $44.1K | ﹤0.01% |
+20,907
| New | +$41.5K |
|
2479
Biote Corp
BTMD
$70.7M
| $40K | ﹤0.01% |
+15,366
| New | +$42K |
|
2480
Evotec
EVO
$991M
| $39.8K | ﹤0.01% |
+12,923
| New | +$44.3K |
|
|
AMBR
2481
Amber International Holding Ltd
AMBR
$133M
| $39.5K | ﹤0.01% |
22,856
-85,450
| -79% | -$169K |
|
|
BHR
2482
Braemar Hotels & Resorts
BHR
$141M
| $38K | ﹤0.01% |
13,233
-79,071
| -86% | -$213K |
|
2483
Cognition Therapeutics
CGTX
$97.6M
| $37.2K | ﹤0.01% |
+27,577
| New | +$44.8K |
|
2484
Protalix BioTherapeutics
PLX
$197M
| $34.3K | ﹤0.01% |
+19,079
| New | +$39K |
|
|
APLT
2485
DELISTED
Applied Therapeutics
APLT
| $33.7K | ﹤0.01% |
337,389
-2,205,299
| -87% | -$1.4M |
|
2486
Kosmos Energy
KOS
$1.25B
| $30.3K | ﹤0.01% |
33,272
-12,554
| -27% | -$16.5K |
|
2487
ALX Oncology
ALXO
$286M
| $29.8K | ﹤0.01% |
26,376
-13,207
| -33% | -$20K |
|
|
CURR
2488
Currenc Group
CURR
$346M
| $18.9K | ﹤0.01% |
+10,535
| New | +$23.6K |
|
2489
Accuray
ARAY
$28.7M
| $18K | ﹤0.01% |
21,914
-470,267
| -96% | -$587K |
|
2490
Atossa Therapeutics
ATOS
$23.6M
| $16.6K | ﹤0.01% |
1,871
-3,801
| -67% | -$48.1K |
|
2491
VistaGen Therapeutics
VTGN
$10.6M
| $13.2K | ﹤0.01% |
+19,973
| New | +$72.1K |
|
|
FSP
2492
Franklin Street Properties
FSP
$52.9M
| $12.9K | ﹤0.01% |
13,600
-129,601
| -91% | -$151K |
|
|
IRBT
2493
DELISTED
iRobot
IRBT
| $3.44K | ﹤0.01% |
31,278
-247,700
| -89% | -$746K |
|
2494
AbCellera Biologics
ABCL
$2.08B
| – | – |
-47,480
| Closed | -$239K |
|
2495
Abeona Therapeutics
ABEO
$398M
| – | – |
-11,800
| Closed | -$62.3K |
|
|
ABX
2496
Abacus Global Management
ABX
$1.07B
| – | – |
-402,726
| Closed | -$2.31M |
|
2497
Arcosa
ACA
$7.12B
| – | – |
-50,609
| Closed | -$4.74M |
|
2498
Adicet Bio
ACET
$82.5M
| – | – |
-3,233
| Closed | -$41.9K |
|
2499
Albertsons Companies
ACI
$7.23B
| – | – |
-1,301,780
| Closed | -$22.8M |
|
2500
Axcelis
ACLS
$4.41B
| – | – |
-25,684
| Closed | -$2.51M |
|
Similar funds
